Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Community Mental Health Journal
Published in: Community Mental Health Journal 3/2010

01-06-2010 | Original Paper

Antidepressant and Antipsychotic Use and Adherence Among Medicaid Youths: Differences by Race

Authors: Betsy Sleath, Marisa E. Domino, Elizabeth Wiley-Exley, Bradley Martin, Shirley Richards, Tim Carey

Published in: Community Mental Health Journal | Issue 3/2010

Login to get access

Abstract

The purpose of our study is to use Medicaid data to examine the relationship between race and (a) whether youth with schizophrenia or depression diagnoses receive anti-psychotic and antidepressant prescriptions and (b) adherence to anti-psychotics and antidepressants. The analysis is based on claims files from January 1, 2000 through June 30, 2001. To assess adherence, we used the Proportion of Days Covered (PDC) measure. Multivariable logistic regression was used to analyze the data. Black children with schizophrenia were significantly less likely to be adherent to anti-psychotics during a quarter than White children. White children with depression were significantly more likely to receive an antidepressant prescription and they were significantly more adherent during a quarter than Black children. Providers should make sure to investigate both youth and caregiver concerns, fears, and barriers to using these medications and work with the families to develop strategies to improve medication use among youth.
Literature
Anderson, R., & Newman, J. (1973). Societal and individual determinants of medical care utilization in the United States. Milbank Memorial Fund Quarterly: Health and Society, 51, 95–124.CrossRef
Aparasu, R. R., Mort, J. R., & Brandt, H. (2003). Psychotropic prescription use by community-dwelling elderly in the United States. Journal of the American Geriatrics Society, 51, 671–677.CrossRefPubMed
Benner, J. S., Glynn, R. J., Mogun, H., Neumann, P. J., Weinstein, M. C., & Avorn, J. (2002). Long-term persistence in use of statin therapy in elderly patients. Journal of the American Medical Association, 288(4), 455–461.CrossRefPubMed
Bush, P. J., & Osterweis, M. (1978). Pathways to medicine use. Journal of Health and Social Behavior, 19, 179–189.CrossRefPubMed
Charach, A., Volpe, T., Boydell, K. M., & Gearing, R. E. (2008). A theoretical approach to medication adherence for children and youth with psychiatric disorders. Harvard Review of Psychiatry, 16(2), 126–135.CrossRefPubMed
Conn, K. M., Halterman, J. S., Fisher, S. G., Yoos, L., Chin, N. P., & Szilagyi, P. G. (2005). Parental beliefs about medications and medication adherence among urban children with youth. Ambulatory Pediatrics, 5, 306–310.CrossRefPubMed
Cooper, L. A., Gonzales, J. J., Gallo, J. J., Rost, K. M., Meredith, L. S., Rubenstein, L. V., et al. (2003). The acceptability of treatment for depression among African-American, hispanic, and white primary care patients. Medical Care, 41(4), 479–489.CrossRefPubMed
Corbie-Smith, G., Thomas, S. B., & St George, D. M. (2002). Distrust, race and research. Archives of Internal Medicine, 162(21), 2458–2463.CrossRefPubMed
Costello, I., Wong, I. C. K., & Nunn, A. J. (2004). A literature review to identify interventions to improve the use of medicines in children. Child: Care, Health and Development, 30(6), 647–665.CrossRef
DiMatteo, M. R. (2004). Variations in patients’ adherence to medical recommendations: A quantitative review of 50 years of research. Medical Care, 42(3), 197–199.CrossRef
Goodwin, R., Gould, M. S., Blanco, C., & Olfson, M. (2001). Prescription of psychotropic medications to youths in office-based practice. Psychiatric Services, 52(8), 1081–1187.CrossRefPubMed
Gray, S. L., Hanlon, J., Fillenbaum, G. G., Wall, W. E., Jr, & Bales, C. (1996). Predictors of nutritional supplement use by the elderly. Pharmacotherapy, 16, 715–720.PubMed
Hahn, B. A. (1995). Children’s health: Racial and ethnic differences in the use of prescription medications. Pediatrics, 95, 727–732.PubMed
Hudson, J. L., Miller, E., & Kirby, J. B. (2007). Explaining racial and ethnic differences in children’s use of stimulant medications. Medical Care, 45(11), 1068–1075.CrossRefPubMed
Marhefka, S., Koenig, L. J., Allison, S., Bachanas, P., Bulterys, M., Bettica, L., et al. (2008). Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications. AIDS Patient Care and STDs, 22(8), 637–647.CrossRefPubMed
Martin, A., Van Hoof, T., Stubbe, D., Sherwin, T., & Scahill, L. (2003). Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut medicaid managed care. Psychiatric Services, 54(1), 72–77.CrossRefPubMed
Martin B.C, Wiley-Exley E., Sichards S., Domino M.E., Carey T.S., Sleath B.L. (2009). Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Annals of Pharmacotherapy, 43(1), 36–44.CrossRef
Matsui, D. (2007). Current issues in pediatric medication adherence. Pediatric Drugs, 9(5), 283–288.CrossRefPubMed
Meichenbaum, D., & Turk, D. (1987). Facilitating Treatment Adherence. NY: Plenum.
Nemeroff, C. B., Kalali, A., Keller, M. B., Charney, D. S., Lenderts, S. E., Cascade, E. F., et al. (2007). Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Archives of General Psychiatry, 64, 466–472.CrossRefPubMed
Olfson, M., Marcus, S. C., & Druss, B. G. (2008). Effects of food and drug administration warnings of antidepressant use in a nation sample. Archives of General Psychiatry, 65(1), 94–101.CrossRefPubMed
Peterson, A. M., Nau, D. P., Cramer, J. A., Benner, J., Gwadry-Sridhar, F., & Nichol, M. (2007). A checklist for medication compliance and persistence studies using retrospective database. Value Health, 10(1), 3–12.CrossRefPubMed
Ragjavan, R., Zima, B. T., Andersen, R. M., Leibowitz, A. A., Schuster, M. A., & Landsverk, J. (2005). Psychotropic medication use in a national probability sample of children in the child welfare system. Journal of Child and Adolescent Psychopharmacology, 15(1), 97–106.CrossRef
Rushton, J. L., & Whitmire, T. (2001). Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends. Archives of Pediatrics and Adolescent Medicine, 155, 560–565.PubMed
Schnittker, J. (2003). Misgivings of medicine?: African Americans’ skepticism of psychiatric medication. Journal of Health and Social Behavior, 44, 506–524.CrossRefPubMed
Sleath, B., Bush, P. J., & Pradel, F. G. (2003). Communicating with children about medicines: A pharmacist’s perspective. American Journal of Health-Systems Pharmacy, 60, 604–607.
Smith, S. R., & Kirking, D. M. (1999). Access and use of medications in HIV disease. Health Services Research, 34, 123–144.PubMed
Svarstad, B. L., Chewning, B. A., & Claesson, C. (1999). The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Education Counseling, 37(2), 113–124.CrossRef
Zito, J. M., Safer, D. J., dosReis, S., & Riddle, M. A. (1998). Racial disparity in psychotropic medication prescribed for youths with medicaid insurance in Maryland. Journal of American Academy of Child & Adolescent Psychiatry, 37(2), 179–184.CrossRef
Zito, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. (2005). Effect of medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services, 56(2), 157–163.CrossRefPubMed
Metadata
Title
Antidepressant and Antipsychotic Use and Adherence Among Medicaid Youths: Differences by Race
Authors
Betsy Sleath
Marisa E. Domino
Elizabeth Wiley-Exley
Bradley Martin
Shirley Richards
Tim Carey
Publication date
01-06-2010
Publisher
Springer US
Published in
Community Mental Health Journal / Issue 3/2010
Print ISSN: 0010-3853
Electronic ISSN: 1573-2789
DOI
https://doi.org/10.1007/s10597-009-9277-5

Other articles of this Issue 3/2010

Community Mental Health Journal 3/2010 Go to the issue

Original Paper

Adolescents’ Attitudes and Opinions about Depression Treatment

Original Paper

A Comparison of Addiction and Transience among Street Youth: Los Angeles, California, Austin, Texas, and St. Louis, Missouri

Original Paper

Patterns of Injury and Childhood Psychiatric Disorder in a Low-Income Population

Brief Report

Assessing and Treating Co-occurring Disorders in Adolescents: Examining Typical Practice of Community-Based Mental Health and Substance Use Treatment Providers

Erratum

Erratum to: Children’s Adjustment and Child Mental Health Service Use: The Role of Parents’ Attitudes and Personal Service Use in an Upper Middle Class Sample

Original Paper

Social Supports for Youth and Families